Medical Cannabis for PTSD: What UK Patients Should Know

PTSD can occur after witnessing or experiencing a traumatic event. It is characterised by intrusive memories (flashbacks, nightmares), avoidance of trauma reminders, negative changes in mood and thinking, and alterations in arousal and reactivity (hypervigilance, sleep problems).

The body's endocannabinoid system (ECS) plays a vital role in regulating mood, memory, sleep, and stress responses. Research suggests that the ECS is fundamentally involved in how we process fear and traumatic memories. In individuals with PTSD, studies have indicated alterations in the ECS, such as lower levels of naturally produced endocannabinoids. THC and CBD, by modulating the ECS, may help to restore balance and alleviate some of the core symptoms of PTSD.

An observational study of 269 UK patients found that treatment with medical cannabis was associated with significant improvements in PTSD symptoms, anxiety, sleep quality, and general health-related quality of life over a period of up to 18 months.

International research supports these findings. A study conducted in Israel on combat veterans with treatment-resistant PTSD found that medical cannabis treatment was associated with a significant reduction in PTSD symptoms. Other studies have highlighted the potential for cannabinoids to help with specific aspects of PTSD, such as reducing nightmares and improving sleep quality.

CBMPs may help manage the challenging symptoms of PTSD in several ways. For intrusive memories and flashbacks, THC may help to reduce the emotional intensity of traumatic memories by modulating activity in the amygdala. For hyperarousal and anxiety, CBD has demonstrated anxiolytic properties that can reduce the heightened state of alertness common in PTSD. For sleep disturbances and nightmares, both THC and CBD can improve sleep quality and reduce nightmare frequency — one of the most debilitating aspects of PTSD.

For avoidance and emotional numbing, by reducing anxiety and improving sleep, CBMPs may help patients engage more effectively with other therapies such as trauma-focused CBT.

If you have been diagnosed with PTSD and conventional treatments — including trauma-focused therapy and medication — have not provided adequate relief, you may be eligible for a CBPM prescription. The process involves registering as a patient, attending a consultation with a specialist clinician, and — if appropriate — receiving a private prescription.

MEDCANN Pharmacy works with specialist clinicians who have extensive experience in prescribing CBMPs for PTSD and other mental health conditions. Register as a patient today to begin your assessment.

Veterans and emergency service workers (including police officers, paramedics, and firefighters) are disproportionately affected by PTSD. The nature of their work exposes them to repeated traumatic events, and many find that conventional treatments do not adequately address the severity of their symptoms.

For this group, medical cannabis has shown particular promise. Several studies specifically involving combat veterans have demonstrated meaningful reductions in PTSD symptom severity, including improvements in hypervigilance, emotional reactivity, and sleep quality. UK-based charities and veteran support organisations have increasingly recognised the potential role of medical cannabis in supporting this population.

MEDCANN Pharmacy is experienced in working with veterans and emergency service workers. Our clinical team understands the specific challenges this group faces and is committed to providing compassionate, informed care.

Medical cannabis is most effective for PTSD when used as part of a comprehensive treatment plan that includes psychological therapy. Trauma-focused CBT (cognitive behavioural therapy) and EMDR (eye movement desensitisation and reprocessing) are the gold-standard psychological treatments for PTSD, and CBMPs can enhance their effectiveness by reducing the hyperarousal and anxiety that often prevent patients from fully engaging with therapy.

Some patients find that CBMPs help them reach a calmer baseline state from which they can more productively engage with trauma processing. This is not a replacement for therapy — it is a tool that can make therapy more accessible and effective.

Your prescribing clinician will work with your psychological therapist to coordinate your care and ensure that your CBMP treatment supports rather than interferes with your therapeutic progress.